A decade out from VOICE & FEM PrEP, and we still see that poor oral PrEP adherence drives HIV acquisitions in Purpose 1. Excellent presentation on the F/TAF data. So, have we learned anything new? At least we maybe know how to use these TAF data, but whatโs next to get TAF approved? #CROI #HIVsky
Posts by Matt Gravett MD MSPH
Speaking at the #CROI2025 symposium on LA #PrEP, Cissy Kityo of JCRC calls on the field to learn lessons from oral PrEP and finally speed scale up of long-acting PrEP. It's not just the product, it's the price and commitments to purchase product that will speed rollout.
Promising new data for on-demand PrEP strategies for ciswomen! Itโs about damn time we catch up with more options for protecting women!
#CROI #CROI2025 #HIVsky
Rebecca Denison gave a sobering and intense call to action. They wonโt stop, and neither will we. #CROI #CROI2025 #HIVsky
Ok jk. Itโs actually Leslie and Ben.
Iโm starting a new writing group with Carrie, Miranda, and Charlotte. Samantha is busy. Who do you write with? #IDSky
PEPFAR waiver in place. #econsky
Long-time lurker, first-time poster.